ConductScience.org, home

Paper17699366

Light-chain (AL) amyloidosis: diagnosis and treatment.

Sanchorawala V. Clin J Am Soc Nephrol, 2006. Cited by 159 papers, by iCite.

Cite this record

ConductScience Library. Light-chain (AL) amyloidosis: diagnosis and treatment. Papers, record 17699366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17699366

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Light-chain (AL) amyloidosis: diagnosis and treatment.
PubMed
Journal
Clin J Am Soc Nephrol
PubMed
Year
2006
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
159
iCite
Relative citation ratio, by iCite
4.34
iCite
Revised in PubMed
2022-04-08
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sanchorawala VVaishali

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AmyloidosisMajor topic
Immunoglobulin Light ChainsMajor topic
KidneyMajor topic
Heart Ventricles
Hodgkin Disease
Humans
Microfibrils
Myocardium
Prognosis

Source PubMed

Download CSV of topics

Cited by90

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 159 citations.

PMIDTitleJournalYearIn PapersSource
42653701Hepatotoxicity Profile of Bortezomib-Containing Regimens for First-Line Multiple Myeloma Treatment.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42653701PubMed
40709584Modeling immunoglobulin light chain amyloidosis in Caenorhabditis elegans.Dis Model Mech2025https://conductscience.org/library/papers/40709584PubMed
40330158Light-Chain (AL) Amyloidosis as a Rare Cause of Upper Gastrointestinal Bleeding: A Case Report and Systematic Literature Review.Case Rep Oncol2025https://conductscience.org/library/papers/40330158PubMed
40045069Detection of protein oligomers with nanopores.Nat Rev Chem2025https://conductscience.org/library/papers/40045069PubMed
38642804Broken but not beaten: Challenge of reducing the amyloids pathogenicity by degradation.J Adv Res2025https://conductscience.org/library/papers/38642804PubMed
38338870Re-Engineering Therapeutic Anti-Aβ Monoclonal Antibody to Target Amyloid Light Chain.Int J Mol Sci2024https://conductscience.org/library/papers/38338870PubMed
38132175Autologous Stem Cell Transplant in Hodgkin's and Non-Hodgkin's Lymphoma, Multiple Myeloma, and AL Amyloidosis.Cells2023https://conductscience.org/library/papers/38132175PubMed
37421149Amyloidoma and Plasmacytoma Presented as a Solitary Lung Nodule in a Patient of Multiple Myeloma With AL-Amyloidosis: A Case Report and Review of Literature.J Investig Med High Impact Case Rep2023https://conductscience.org/library/papers/37421149PubMed
37342296Need for Early Recognition of Amyloidosis in Cases of Unexplained Heart Failure: A Case Report.Cureus2023https://conductscience.org/library/papers/37342296PubMed
37220448A Rare Case of Gastrointestinal Amyloidosis Due to Monoclonal Gammopathy of Undetermined Significance.Cureus2023https://conductscience.org/library/papers/37220448PubMed
37185541Non-Perturbative Identification and Subtyping of Amyloidosis in Human Kidney Tissue with Raman Spectroscopy and Machine Learning.Biosensors (Basel)2023https://conductscience.org/library/papers/37185541PubMed
36982754Machine Learning Approaches in Diagnosis, Prognosis and Treatment Selection of Cardiac Amyloidosis.Int J Mol Sci2023https://conductscience.org/library/papers/36982754PubMed
36606280Changing paradigm in the treatment of amyloidosis: From disease-modifying drugs to anti-fibril therapy.Front Cardiovasc Med2022https://conductscience.org/library/papers/36606280PubMed
36574171A comprehensive overview of AL amyloidosis disease characteristics accumulated over two decades at a single referral center in Korea.Int J Hematol2023https://conductscience.org/library/papers/36574171PubMed
36444232AL Amyloidosis for Cardiologists: Awareness, Diagnosis, and Future Prospects: JACC: CardioOncology State-of-the-Art Review.JACC CardioOncol2022https://conductscience.org/library/papers/36444232PubMed
36313726Clinical characteristics and prognostic value of renal immune complex deposition in patients with light chain amyloidosis.Front Oncol2022https://conductscience.org/library/papers/36313726PubMed
36164377Isolated prostate amyloidosis; a case report.Urol Case Rep2022https://conductscience.org/library/papers/36164377PubMed
35371791Multiple Myeloma and Renal Failure: Mechanisms, Diagnosis, and Management.Cureus2022https://conductscience.org/library/papers/35371791PubMed
35281154Oral amyloidosis: A case report and diagnostic algorithm.J Oral Maxillofac Pathol2021https://conductscience.org/library/papers/35281154PubMed
34729532How to Screen for Monoclonal Gammopathy in Patients With a Suspected Amyloidosis.JACC CardioOncol2021https://conductscience.org/library/papers/34729532PubMed

See all 90 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17699366

GET https://conductscience.org/api/papers/v1/17699366/cited_by?page=2